ArticleOphthalmology and therapy2026
Safety of GBL1204-An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study.
Amit Saraf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.